Evidence map›Paper›PMID 34710096›Full record

ArticlePLoS computational biology2021

Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing.

Emily Howerton, Matthew J Ferrari, Ottar N Bjørnstad, Tiffany L Bogich, Rebecca K Borchering, Chris P Jewell, James D Nichols, William J M Probert, Michael C Runge, Michael J Tildesley and 2 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emily HowertonCenter for Infectious Disease Dynamics, The Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0002-0639-3728
Matthew J FerrariCenter for Infectious Disease Dynamics, The Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0001-5251-8168
Ottar N BjørnstadCenter for Infectious Disease Dynamics, The Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0002-1158-3753
Tiffany L BogichCenter for Infectious Disease Dynamics, The Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0002-8143-5289
Rebecca K BorcheringCenter for Infectious Disease Dynamics, The Pennsylvania State University, University Park, Pennsylvania, United States of America.ORCID 0000-0003-4309-2913
Chris P JewellLancaster Medical School, Lancaster University, Lancaster, United Kingdom.ORCID 0000-0002-7902-2178
James D NicholsU.S. Geological Survey, Eastern Ecological Science Center at the Patuxent Research Refuge, Laurel, Maryland, United States of America.ORCID 0000-0002-7631-2890
William J M ProbertBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-3437-759X
Michael C RungeU.S. Geological Survey, Eastern Ecological Science Center at the Patuxent Research Refuge, Laurel, Maryland, United States of America.ORCID 0000-0002-8081-536X
Michael J TildesleyZeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), Mathematics Institute and School of Life Sciences, University of Warwick, Coventry, United Kingdom.ORCID 0000-0002-6875-7232
Cécile ViboudFogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America.ORCID 0000-0003-3243-4711
Katriona SheaCenter for Infectious Disease Dynamics, The Pennsylvania State University, University Park, Pennsylvania, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stay-at-home orders and shutdowns of non-essential businesses are powerful, but socially costly, tools to control the pandemic spread of SARS-CoV-2. Mass testing strategies, which rely on widely administered frequent and rapid diagnostics to identify and isolate infected individuals, could be a potentially less disruptive management strategy, particularly where vaccine access is limited. In this paper, we assess the extent to which mass testing and isolation strategies can reduce reliance on socially costly non-pharmaceutical interventions, such as distancing and shutdowns. We develop a multi-compartmental model of SARS-CoV-2 transmission incorporating both preventative non-pharmaceutical interventions (NPIs) and testing and isolation to evaluate their combined effect on public health outcomes. Our model is designed to be a policy-guiding tool that captures important realities of the testing system, including constraints on test administration and non-random testing allocation. We show how strategic changes in the characteristics of the testing system, including test administration, test delays, and test sensitivity, can reduce reliance on preventative NPIs without compromising public health outcomes in the future. The lowest NPI levels are possible only when many tests are administered and test delays are short, given limited immunity in the population. Reducing reliance on NPIs is highly dependent on the ability of a testing program to identify and isolate unreported, asymptomatic infections. Changes in NPIs, including the intensity of lockdowns and stay at home orders, should be coordinated with increases in testing to ensure epidemic control; otherwise small additional lifting of these NPIs can lead to dramatic increases in infections, hospitalizations and deaths. Importantly, our results can be used to guide ramp-up of testing capacity in outbreak settings, allow for the flexible design of combined interventions based on social context, and inform future cost-benefit analyses to identify efficient pandemic management strategies.

Indexed as

SARS-CoV-2Communicable Disease ControlComputational BiologyComputer SimulationCost-Benefit AnalysisCOVID-19COVID-19 TestingHumansModels, BiologicalPandemicsPhysical Distancing

Identifiers

PMID34710096
PMCPMC8553097

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.